Alyeska Investment Group »

Lb Pharmaceuticals shares owned by Alyeska Investment Group

Quarter-by-quarter ownership of Lb Pharmaceuticals (LBRX) shares owned by Alyeska Investment Group from 13F filings

Historical chart of Alyeska Investment Group investment in Lb Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lb Pharmaceuticals held by Alyeska Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lb Pharmaceuticals by Alyeska Investment Group

Quarter filed Position value Share count Share price at filing
2026-03-31 $21M 864k 24.64
2025-12-31 $15M 675k 22.26
2025-09-30 $11M 675k 15.79

More positions owned by Alyeska Investment Group

Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Micron Technology (MU)
Robinhood Mkts Com Cl A (HOOD)
Coreweave Com Cl A (CRWV)
Meta Platforms Cl A (META)
Uber Technologies (UBER)
Gpgi Com Cl A (GPGI)
Amphenol Corp Cl A (APH)
Cisco Systems (CSCO)
Hilton Worldwide Holdings (HLT)
Burlington Stores (BURL)
Merck & Co (MRK)
Zebra Technologies Corporati Cl A (ZBRA)

View all positions for Alyeska Investment Group

Top funds holding Lb Pharmaceuticals

Deep Track Capital
BlackRock
RA Capital Management
TCG Crossover Management
Commodore Capital
Trails Edge Capital Partners
Vanguard Group
Nantahala Capital Management
Balyasny Asset Management
Logos Global Management
Vanguard Capital Management
Alyeska Investment Group
Vivo Capital
Jennison Associates
Geode Capital Management

View all funds holding Lb Pharmaceuticals